| Identification | Back Directory | [Name]
N-(4-(4-(3-Methyl-1H-pyrazol-5-ylaMino)-6-(4-Methylpiperazin-1-yl)pyriMidin-2-ylthio)phenyl)propionaMide | [CAS]
639089-73-9 | [Synonyms]
N-(4-(4-(3-Methyl-1H-pyrazol-5-ylaMino)-6-(4-Methylpiperazin-1-yl)pyriMidin-2-ylthio)phenyl)propionaMide
Propanamide, N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]- | [Molecular Formula]
C22H28N8OS | [MDL Number]
MFCD32068314 | [MOL File]
639089-73-9.mol | [Molecular Weight]
452.58 |
| Hazard Information | Back Directory | [Description]
VE-465 is a novel Aurora kinase inhibitor. The Aurora kinase family of kinases (Aurora A, B, and C) are involved in multiple mitotic events, and aberrant expression of these kinases is associated with tumorigenesis. |
|
| Company Name: |
ChemCell Biomedicine Co.,Ltd.
|
| Tel: |
020-13556033878 2965585218 13556033878 |
| Website: |
https://www.chemicalbook.com/ShowSupplierProductsList15061/0.htm |
|